M. Humbert (Le Kremlin-Bicêtre, France), S. Ulrich (Zurich, Switzerland), M.M. Hoeper (Hannover, Germany), A. Vonk Noordegraaf (Amsterdam, The Netherlands)
Would RDW be a prognostic factor in pulmonary arterial hypertension?
K. C. Tertemiz, B. Akdeniz, A. Ozgen Alpaydin, A. M. Birlik, N. Baris, C. Sevinc (Izmir, Turkey)
|  |
Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension
L. Savale, J. Le Pavec, O. Mercier, S. Mussot, D. Fabre, X. Jais, D. Montani, O. Sitbon, M. Humbert, G. Simonneau, P. Dartevelle, E. Fadel (Le Kremlin Bicêtre, Le Plessis Robinson, France)
| |
Epoprostenol dosing by concomitant therapies in the PROSPECT registry
M. Chakinala, R. Frantz, R. Schilz, W. Benton, D. Miller, B. Hartline, C. L. Vampola, D. Rosenberg, H. Farber (St. Louis, Rochester, Cleveland, South San Francisco, San Francisco, Boston, United States Of America; Allschwil, Switzerland)
| |
Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension
R. Quarck, T. De Ravel, C. Belge, W. Wuyts, B. Cools, M. Delcroix (Leuven, Belgium)
| |
Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study
E. Nikolaeva, I. Kurmukov, N. Yudkina, A. Volkov (Moscow, Russian Federation)
|  |
Studying quality of life in PAH: Patient-reported outcome assessment and psychosocial evaluation in a 6 months follow-up
L. Halimi, N. Molinari, C. Briand, A. S. Gamez, N. Collin, I. Vachier, A. Bourdin (Montpellier, France)
| |
Relevance of echocardiographic composite index to improve the detection of pulmonary hypertension
B. Lamia, L. C. Molano, C. Viacroze, C. Gounane, A. Cuvelier, J. F. Muir (Rouen, France)
| |
Muscle function and physical activity in patients with idiopathic pulmonary arterial hypertension (IPAH)
B. Garfield, L. Parfitt, C. Harries, P. Marino, R. Alonso-Gonzalez, K. Dimopoulos, P. Kemp, M. Polkey, S. J. Wort (London, United Kingdom)
| |
Cardiac output by direct Fick, thermodilution and modelflow in pre-capillary pulmonary hypertension
F. Lador, G. Garcia, A. Bringard, G. Ferretti, P. M. Soccal, G. Simonneau, P. Hervé, O. Sitbon (Geneva 14, Geneva, Switzerland; Le Kremlin Bicêtre, Le Plessis-Robinson, France)
| |
Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire
A. Reis, J. Twiss, M. Vicente, F. Gongalves, L. Carvalho, A. Melo, S. P. McKena, L. Almeida (Porto, Aviero, Portugal; Manchester, United Kingdom)
| |
Correlations between clinical variables and quality of life in pulmonary arterial hypertension
A. Reis, M. Vicente, L. Carvalho, A. Melo, F. Gonçalves, L. Almeida (Porto, Aveiro, Portugal)
| |
Long-term data from the Swiss pulmonary hypertension registry
S. Ulrich, H. Stricker, T. Geiser, S. Keusch, E. Hasler, P. Grendelmeier, J. M. Fellrath, F. Lador, M. Schwerzmann, D. Weilenmann, O. Schoch, V. Popov, T. Rochat, A. Azzola, M. Beghetti, L. Nicod, R. Speich, L. Huber, G. Domenighetti, J. D. Aubert, M. Tamm, S. Müller-Mottet (Zürich, Locarno, Lugano, Basel, Bern, Neuchatel, Geneva, St. Gallen, Lucerne, Lausanne, Switzerland)
| |
Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH)
T. Urushibara, N. Tanabe, R. Suda, F. Kato, H. Kasai, A. Sekine, R. Nishimura, T. Jujo, T. Sugiura, S. Sakao, Y. Kasahara, K. Tatsumi (Chiba, Japan)
| |
Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study
P. Amedro, A. Basquin, V. Gressin, P. Clerson, X. Jais, J. B. Thambo, D. Bonnet (Montpellier, Rennes, Paris, Roubaix, Le Kremlin Bicêtre, Bordeaux, France)
| |
A thriathlete with acute onset of dyspnea and hemoptysis
K. Pintscher, M. Hubner, M. Kneussl (Vienna, Austria)
| |
A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
L. Parfitt, P. Marino, C. Harries, K. Dimopoulos, J. Wort (London, United Kingdom)
| |
Usefulness of NT-proBNP dosage during the follow-up of PAH: Comparison with 6MWD
G. Paciocco, S. Gamberini, L. Novelli, A. Lucenti, A. Vincenzi, A. Pesci (Monza, Italy)
| |
Pulmonary arterial hypertension – A single-centre experience
A. Reis, A. Gomes, M. Ricardo, C. Cruz, J. Rocha, L. Carvalho, F. Gonçalves (Porto, Portugal)
| |
Detection of hepatopulmonary syndrome in patients with liver cirrhosis using 3D contrast echocardiography
R. Gaber, D. H. Ziada, N. A. Kotb, G. H. Abo El-Magd, M. Hamisa (Tanta, Egypt)
| |
Early screening for reperfusionand CTEPH after acute pulmonary embolism – Early screening for reperfusion and CTEPH after acutepulmonary embolism
B. Fuchs, H. Vogelsinger, C. M. Kaehler (Innsbruck, Austria)
| |